Home
Engitix

Engitix Market Share Analysis for May 2026

Find us at White City Place, a new life sciences cluster in London, UK

Industry: N/A

Domainengitix.com

Year Founded2016

Employees51 - 200

Annual Revenue$5M - $10M

Engitix

Engitix (including company regionals)

engitix.com

See more website traffic and engagement information

Engitix Revenue up to May 2026 is 5M - 10M

revenue generated by Engitix top domains

Engitix top domains revenue over 3 years

Revenue for Engitix top domains

engitix.com5M - 10M

See more with Sales Intelligence

Total visits to Engitix's top domains

Understand Engitix market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

engitix.com870

See more with Sales Intelligence

Avg. visit duration in Engitix's top domains

Analyze Engitix engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

engitix.com00:00:01

See more with Sales Intelligence

Avg. pageviews on Engitix's top domains

See how Engitix keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

engitix.com1.28

See more with Sales Intelligence

Engitix top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by Engitix

These are the website technologies, by industry, used by Engitix top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Email Services (2)

G Suite

Marketing (2)

Google Marketing Platform

More Technologies

6

See all

News & Signals from Engitix

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEngitix Ltd is developing human ECM-based disease models on Jun 8th '26.Engitix will develop human ECM-based disease models and generate high-resolution translational multi-omics datasets, to uncover novel targets associated with fibrosis resolution in liver disease.

NewsEngitix Ltd partners with GlaxoSmithKline.Extracellular matrix (ECM) specialist Engitix Ltd. is teaming up with GSK plc to delve into the mechanisms underlying regression of fibrosis after treatment for chronic liver disease, and identify and validate new drug targets involved in this process.

NewsEngitix Ltd is developing therapeutic targets for liver fibrosis regression.Engitix partners with GSK to develop new treatments targeting liver fibrosis regression.